151 related articles for article (PubMed ID: 15587972)
1. Comparison of two design optimality criteria applied to a nonlinear model.
Bogacka B; Wright F
J Biopharm Stat; 2004 Nov; 14(4):909-30. PubMed ID: 15587972
[TBL] [Abstract][Full Text] [Related]
2. Optimal design criteria for discrimination and estimation in nonlinear models.
Waterhouse TH; Eccleston JA; Duffull SB
J Biopharm Stat; 2009; 19(2):386-402. PubMed ID: 19212887
[TBL] [Abstract][Full Text] [Related]
3. Comparison of robust criteria for D-optimal designs.
Foo LK; McGree J; Eccleston J; Duffull S
J Biopharm Stat; 2012; 22(6):1193-205. PubMed ID: 23075017
[TBL] [Abstract][Full Text] [Related]
4. Methods of robust design of nonlinear models with an application to pharmacokinetics.
Foo LK; Duffull S
J Biopharm Stat; 2010 Jul; 20(4):886-902. PubMed ID: 20496212
[TBL] [Abstract][Full Text] [Related]
5. A program for the optimum design of pharmacokinetic, pharmacodynamic, drug metabolism and drug-drug interaction models.
Graham G; Gueorguieva I; Dickens K
Comput Methods Programs Biomed; 2005 Jun; 78(3):237-49. PubMed ID: 15899308
[TBL] [Abstract][Full Text] [Related]
6. A generalisation of T-optimality for discriminating between competing models with an application to pharmacokinetic studies.
Vajjah P; Duffull SB
Pharm Stat; 2012; 11(6):503-10. PubMed ID: 23059829
[TBL] [Abstract][Full Text] [Related]
7. Compound optimal design criteria for nonlinear models.
McGree JM; Eccleston JA; Duffull SB
J Biopharm Stat; 2008; 18(4):646-61. PubMed ID: 18607799
[TBL] [Abstract][Full Text] [Related]
8. Crossover designs with correlated observations.
Donev AN
J Biopharm Stat; 1998 May; 8(2):249-62. PubMed ID: 9598421
[TBL] [Abstract][Full Text] [Related]
9. D-optimal cohort designs for linear mixed-effects models.
Tekle FB; Tan FE; Berger MP
Stat Med; 2008 Jun; 27(14):2586-600. PubMed ID: 17726724
[TBL] [Abstract][Full Text] [Related]
10. Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models.
Nguyen TT; Bazzoli C; Mentré F
Stat Med; 2012 May; 31(11-12):1043-58. PubMed ID: 21965170
[TBL] [Abstract][Full Text] [Related]
11. Curvature-adjusted optimal design of sampling times for the inference of pharmacokinetic compartment models.
Daimon T; Goto M
Stat Med; 2007 Jun; 26(14):2799-812. PubMed ID: 17072822
[TBL] [Abstract][Full Text] [Related]
12. Optimal design of mixed-effects PK/PD models based on differential equations.
Wang Y; Eskridge KM; Nadarajah S
J Biopharm Stat; 2012; 22(1):180-205. PubMed ID: 22204534
[TBL] [Abstract][Full Text] [Related]
13. Using nonlinear models in fMRI data analysis: model selection and activation detection.
Deneux T; Faugeras O
Neuroimage; 2006 Oct; 32(4):1669-89. PubMed ID: 16844388
[TBL] [Abstract][Full Text] [Related]
14. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.
Comets E; Brendel K; Mentré F
Comput Methods Programs Biomed; 2008 May; 90(2):154-66. PubMed ID: 18215437
[TBL] [Abstract][Full Text] [Related]
15. Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0.
Bazzoli C; Retout S; Mentré F
Comput Methods Programs Biomed; 2010 Apr; 98(1):55-65. PubMed ID: 19892427
[TBL] [Abstract][Full Text] [Related]
16. An effective approach for obtaining optimal sampling windows for population pharmacokinetic experiments.
Ogungbenro K; Aarons L
J Biopharm Stat; 2009; 19(1):174-89. PubMed ID: 19127474
[TBL] [Abstract][Full Text] [Related]
17. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
Bazzoli C; Retout S; Mentré F
Stat Med; 2009 Jun; 28(14):1940-56. PubMed ID: 19266541
[TBL] [Abstract][Full Text] [Related]
18. Design in nonlinear mixed effects models: optimization using the Fedorov-Wynn algorithm and power of the Wald test for binary covariates.
Retout S; Comets E; Samson A; Mentré F
Stat Med; 2007 Dec; 26(28):5162-79. PubMed ID: 17486667
[TBL] [Abstract][Full Text] [Related]
19. Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics.
Retout S; Mentré F; Bruno R
Stat Med; 2002 Sep; 21(18):2623-39. PubMed ID: 12228881
[TBL] [Abstract][Full Text] [Related]
20. Combined genetic algorithm and multiple linear regression (GA-MLR) optimizer: Application to multi-exponential fluorescence decay surface.
Fisz JJ
J Phys Chem A; 2006 Dec; 110(48):12977-85. PubMed ID: 17134156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
